
Cure51
Innovative French TechBio company dedicated to finding novel Cancer treatments based on exceptional Cancer survivors' biology.
$16M Seed ·
Source: startupintros.com
Funding history ↓Signals
Website registeredSep 27, 2021 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $16M | — | startupintros.com |
Timeline
- Website created
Founders and team
- NWNICOLAS WOLIKOW Co-Founder CEOsource: cure51.com
- EMEL MEHDI OUZGANE Late Founder COOsource: cure51.com
- PCPALOMA CEJAS Late Founder Head of Translational Researchsource: cure51.com
- RNRÉMY NICOLLE Late Founder Senior Advisorsource: cure51.com
- SISIMON ISTOLAINEN Co-Founder Chief Strategy Officersource: cure51.com
Companies like Cure51
OOna Therapeutics$86.6M Series B+ · Oct 2026
PPersevere Therapeutics$1.5M Seed · Mar 2026
OOncoC4$50M Series B+ · Oct 2025
AATB Therapeutics$57M Series A · Dec 2024
MMariana Oncology$175M Series B+ · Sep 2023
HHumanImageSeed · Apr 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cure51 (get a free API key).